Celltrion Healthcare Netherlands B.V.

Company number 0718.720.411

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 27
Amount won alone: €38,581,876 excl. VAT
Shared contracts: 12 (multi-supplier framework agreements)
Period: 12 January 2024 – 7 October 2026

Its main clients

AZ Delta vzw · 4 contracts
Cliniques universitaires Saint Luc · 4 contracts
VITAZ vzw · 3 contracts
UZ Leuven · 2 contracts
VZW Maria Middelares · 2 contracts
Universitair Ziekenhuis Gent · 2 contracts
Hospilim VZW · 2 contracts
Vivalia · 2 contracts
AZ Sint-Lucas vzw · 1 contract
AZ Sint-Lucas Brugge vzw · 1 contract

Where and what

Supplies · 27

East Flanders · 8 West Flanders · 7 Brussels-Capital · 4 Flemish Brabant · 2 Limburg · 2 Namur · 1 Hainaut · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
11 May 2027 re-tender around November 2026	Raamovereenkomst voor de aankoop en levering van Infliximab IV VZW Maria Middelares framework agreement	Celltrion Healthcare Netherlands B.V. 1 bid received	€22,100,000
9 November 2027 re-tender around May 2027	Leveren van een terugbetaalde vorm van Bevacizumab 100 mg/4 ml en 400 mg/ 16ml voor intraveneus gebruik UZ Leuven framework agreement	AMGEN Celltrion Healthcare Netherlands B.V. EG 3 bids received	€2,943,059
1 December 2027 re-tender around June 2027	Fourniture 'd'anastroazole, anagrelide, letrozole, bevacizumab, bortezomib et de fulvestrant 2023-2027 HUmani SC framework agreement	Arega Pharma BV Celltrion Healthcare Netherlands BV Eurogenerics Pharmanovia Benelux B.V. 7 bids received	€832,552
12 December 2027 re-tender around June 2027	Raamovereenkomst voor het leveren van Cytostatica Parenteraal Hospilim VZW framework agreement	Roche NV Accord Healthcare BV Celltrion Healthcare Netherlands BV Pharmanovia Benelux BV Viatris BV Fresenius Kabi NV Baxter Belgium SRL Aurobindo NV AstraZeneca NV Arega Pharma BV Servier Benelux NV MSD Belgium BV Sandoz NV 4 bids received	€375,000,000
26 July 2028 re-tender around January 2028	Monoklonale antilichamen - Trastuzumab 2024 VITAZ vzw framework agreement	Celltrion Healthcare Netherlands B.V. ROCHE SA 1 bid received	€2,362,513
26 July 2028 re-tender around January 2028	Monoklonale antilichamen - Rituximab 2024 VITAZ vzw framework agreement	Celltrion Healthcare Netherlands B.V. ROCHE SA 2 bids received	€1,200,479
18 November 2028 re-tender around May 2028	Accord-cadre relatif à la fourniture de TRASTUZUMAB et RITUXIMAB IV pour les besoins des pharmacies de Vivalia, agissant en Centrale d’achats Vivalia framework agreement	Celltrion Healthcare Netherlands B.V. 2 bids received	–
18 February 2029 re-tender around August 2028	Raamovereenkomst voor het leveren van rituximab en trastuzumab Universitair Ziekenhuis Gent framework agreement	Sandoz nv Roche Celltrion Healthcare Netherlands 4 bids received	€8,618,346
28 February 2029 re-tender around August 2028	Rituximab et Trastuzumab Cliniques universitaires Saint Luc framework agreement	Celltrion Healthcare Netherlands B.V. 2 bids received	€1,610,000
15 April 2029 re-tender around October 2028	Raamovereenkomst voor het leveren van infliximab Universitair Ziekenhuis Gent framework agreement	Celltrion Healthcare Netherlands B.V. 1 bid received	€4,100,910
19 May 2029 re-tender around November 2028	Leveren van Trastuzumab en Rituximab voor intraveneus gebruik UZ Leuven framework agreement	Celltrion Healthcare Netherlands B.V. BIOSIMILAR COLLABORATIONS IRELAND LIMITED Pfizer sandoz 3 bids received	€4,264,649

Contracts won

Date	Contract	Buyer	Amount
07/10/2026	Raamovereenkomst voor de levering van Tocilizumab	AZ Sint-Lucas vzw	€1,229,160
08/09/2026	Aflibercept	AZ Delta vzw	€4,424,940
19/08/2026	Rituximab	Cliniques universitaires Saint Luc	€628,800
19/08/2026	Infliximab	Cliniques universitaires Saint Luc	€2,492,000
07/07/2026	Bévacizumab	Cliniques universitaires Saint Luc	€503,440
01/07/2026	Leveren van een terugbetaalde vorm van Bevacizumab 100 mg/4 ml en 400 mg/ 16ml voor intraveneus gebruik	UZ Leuven	€2,943,059 shared by 3
18/06/2026	Tocilizumab IV	AZ Delta vzw	€385,370
29/04/2026	Denosumab	VITAZ vzw	€1,047,820 shared by 2
07/04/2026	Parenterale cytostatica	AZ Delta vzw	€3,950,688 shared by 12
12/11/2025	Leveren van Trastuzumab en Rituximab voor intraveneus gebruik	UZ Leuven	€4,264,649 shared by 4
19/05/2025	Raamovereenkomst voor de aankoop en levering van Infliximab IV	VZW Maria Middelares	€22,100,000
14/04/2025	Raamovereenkomst voor het leveren van rituximab en trastuzumab	Universitair Ziekenhuis Gent	€8,618,346 shared by 3
14/04/2025	Raamovereenkomst voor het leveren van infliximab	Universitair Ziekenhuis Gent	€4,100,910
19/03/2025	Raamovereenkomst voor de levering van infliximab	Hospilim VZW	–
06/03/2025	Rituximab et Trastuzumab	Cliniques universitaires Saint Luc	€1,610,000
14/01/2025	Accord-cadre relatif à la fourniture de TRASTUZUMAB et RITUXIMAB IV pour les besoins des pharmacies de Vivalia, agissant en Centrale d’achats	Vivalia	–
10/09/2024	Trastuzumab - Rituximab IV	AZ Delta vzw	€187,182
26/08/2024	Raamovereenkomst voor het aankopen en leveren van Trastuzumab en Rituximab	VZW Maria Middelares	€13,660,477 shared by 3
14/08/2024	Accord-cadre relatif à la fourniture d’INFLIXIMAB pour injection intravitréenne pour les besoins des pharmacies de Vivalia, agissant en Centrale d’achats	Vivalia	–
28/05/2024	Monoklonale antilichamen - Rituximab 2024	VITAZ vzw	€1,200,479 shared by 2
28/05/2024	Monoklonale antilichamen - Trastuzumab 2024	VITAZ vzw	€2,362,513 shared by 2
21/05/2024	Raamovereenkomst voor de levering van Rituximab IV en Trastuzumab IV	AZ Sint-Lucas Brugge vzw	€59,115 shared by 2
29/04/2024	Raamovereenkomst voor leveren van Cytostatica geneesmiddelen	AZ Sint-Jan Brugge AV	€3,379,003 shared by 10
17/04/2024	Raamovereenkomst voor de aankoop en levering van Bevacizumab	AZ Maria Middelares	€920,075
05/03/2024	Fourniture de Trastuzumab IV	MercurHosp ASBL	–
26/01/2024	Raamovereenkomst voor het leveren van Cytostatica Parenteraal	Hospilim VZW	€375,000,000 shared by 13
12/01/2024	Fourniture 'd'anastroazole, anagrelide, letrozole, bevacizumab, bortezomib et de fulvestrant 2023-2027	HUmani SC	€832,552 shared by 4

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.